C WorldWide Group’s Intersect ENT, Inc XENT Stock Holding History

C WorldWide Group’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-123,514	Closed	-$3.97M	–	115
2019 Q1	$3.97M	Hold	123,514	–	–	0.05%	68
2018 Q4	$3.48M	Sell	123,514 -43,819	-26%	-$1.28M	0.05%	58
2018 Q3	$4.81M	Sell	167,333 -2,102	-1%	-$63.1K	0.06%	68
2018 Q2	$6.34M	Buy	169,435 +58,402	+53%	+$2.29M	0.09%	57
2018 Q1	$4.36M	Sell	111,033 -14,857	-12%	-$543K	0.07%	57
2017 Q4	$4.08M	Sell	125,890 -20,836	-14%	-$625K	0.06%	64
2017 Q3	$4.57M	Sell	146,726 -1,272	-0.9%	-$37.6K	0.07%	68
2017 Q2	$4.14M	Sell	147,998 -33,552	-18%	-$760K	0.06%	68
2017 Q1	$3.11M	Buy	181,550 +16,550	+10%	+$232K	0.05%	72
2016 Q4	$2M	Hold	165,000	–	–	0.04%	82
2016 Q3	$2.61M	Buy	+165,000	New	+$2.48M	0.05%	80

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

C WorldWide Group's XENT Position: Q2 2019 in Review

C WorldWide Group sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 123,514 shares — an estimated $3.97M sold.

C WorldWide Group first reported a position in XENT in Q3 2016 and held it in 11 quarters. The position peaked at $6.34M in Q2 2018. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

C WorldWide Group reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
C WorldWide Group sold 123,514 Intersect ENT, Inc shares in Q2 2019, an estimated $3.97M.
C WorldWide Group first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 11 quarters.
C WorldWide Group's Intersect ENT, Inc position peaked at $6.34M in Q2 2018.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.